Hiroshi Inaba

Hiroshi Inaba


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2016 in Chemical Science
Verified
Journal Article
Open access
PDF file
SDStéphane Diring
Stéphane Diring
ACArnau Carné-Sánchez
Arnau Carné-Sánchez
JZJiCheng Zhang
JiCheng Zhang
SIShuya Ikemura
Shuya Ikemura
CKChiwon Kim
Chiwon Kim
SFShuhei Furukawa
Shuhei Furukawa
A new carbon monoxide (CO)-releasing material has been developed by embedding a manganese carbonyl complex, MnBr(bpydc)(CO)3 (bpydc = 5,5′-dicarboxylate-2,2′-bipyridine) into a highly robust Zr(IV)-based metal–organic framework (MOF). Efficient and controllable CO-release was achieved under exposure to low intensity visible light. Size-controllable nanocrystals of the photoactive MOF were obtained and their CO-releasing properties were correlated with their crystal sizes. The photoactive crystals were processed into cellular substrates with a biocompatible polymer matrix, and the light-induced delivery of CO and its subsequent cellular uptake were monitored using a fluorescent CO-probe. The results discussed here demonstrate a new opportunity to use MOFs as macromolecular scaffolds towards CO-releasing materials and the advantage of MOFs for high CO payloads, which is essential in future therapeutic applications.

7 August 2015 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
HIHiroshi Inaba
Hiroshi Inaba
KFKenta Fujita
Kenta Fujita
TUTakafumi Ueno
Takafumi Ueno
Carbon monoxide (CO) is recognized as one of the most important gas signaling molecules involved in governing various therapeutic responses. Intracellular generation of CO is spatiotemporally controlled by catalytic reactions of heme oxygenases (HOs). Thus, the ability to control intracellular CO delivery with modulation of the CO-release rate in specific amounts and locations is expected to improve our fundamental understanding of the functions of CO and the development of clinical applications. For this purpose, CO-releasing molecules (CORMs) have been developed and investigated in vitro and in vivo. Most CORMs are based on transition metal carbonyl complexes. Recently, various biomaterials consisting of metal carbonyls with biomacromolecular scaffolds have been reported to improve the properties of bare metal carbonyls. In this mini-review, current progress in CO delivery, recent strategies for the development of CORMs, and future directions in this field are discussed.

25 July 2018 in ACS Central Science
Verified
Journal Article
Open access
CAChelsea Anorma
Chelsea Anorma
JHJamila Hedhli
Jamila Hedhli
TBThomas E. Bearrood
Thomas E. Bearrood
NPNicholas W. Pino
Nicholas W. Pino
SGSarah H. Gardner
Sarah H. Gardner
JCJefferson Chan
Jefferson Chan
Cancer stem cells (CSCs) are progenitor cells that contribute to treatment-resistant phenotypes during relapse. CSCs exist in specific tissue microenvironments that cell cultures and more complex models cannot mimic. Therefore, the development of new approaches that can detect CSCs and report on specific properties (e.g., stem cell plasticity) in their native environment have profound implications for studying CSC biology. Herein, we present AlDeSense, a turn-on fluorescent probe for aldehyde dehydrogenase 1A1 (ALDH1A1) and Ctrl-AlDeSense, a matching nonresponsive reagent. Although ALDH1A1 contributes to the detoxification of reactive aldehydes, it is also associated with stemness and is highly elevated in CSCs. AlDeSense exhibits a 20-fold fluorescent enhancement when treated with ALDH1A1. Moreover, we established that AlDeSense is selective against a panel of common ALDH isoforms and exhibits exquisite chemostability against a collection of biologically relevant species. Through the application of surface marker antibody staining, tumorsphere assays, and assessment of tumorigenicity, we demonstrate that cells exhibiting high AlDeSense signal intensity have properties of CSCs. Using these probes in tandem, we have identified CSCs at the cellular level via flow cytometry and confocal imaging, as well as monitored their states in animal models.

30 October 2018 in The Chemical Record
Verified
Journal Article
Closed access
PDF file
HIHiroshi Inaba
Hiroshi Inaba
KAZUNORI MATSUURAKAZUNORI MATSUURA
KAZUNORI MATSUURA

26 July 2010 in Small
Verified
Journal Article
Closed access
PDF file
NYNorihiko Yokoi
Norihiko Yokoi
HIHiroshi Inaba
Hiroshi Inaba
MTMakoto Terauchi
Makoto Terauchi
ASAdam Z. Stieg
Adam Z. Stieg
NSNusrat J. M. Sanghamitra
Nusrat J. M. Sanghamitra
TUTakafumi Ueno
Takafumi Ueno

8 August 2018 in Chemistry – A European Journal
Verified
Journal Article
Open access
PDF file
HIHiroshi Inaba
Hiroshi Inaba
TYTakahisa Yamamoto
Takahisa Yamamoto
AKArif Md. Rashedul Kabir
Arif Md. Rashedul Kabir
AKAkira Kakugo
Akira Kakugo
KSKazuki Sada
Kazuki Sada
KAZUNORI MATSUURAKAZUNORI MATSUURA
KAZUNORI MATSUURA
Microtubules are cytoskeletal filaments that serve as attractive scaffolds for developing nanomaterials and nanodevices because of their unique structural properties. The functionalization of the outer surface of microtubules has been established for this purpose. However, no attempts have been made to encapsulate molecules inside microtubules with 15 nm inner diameter. The encapsulation of various molecular cargos inside microtubules constitutes a new concept for nanodevice and nanocarrier applications of microtubules. Here, we developed peptide motifs for binding to the inner surface of microtubules, based on a repeat domain of the microtubule‐associated protein Tau. One of the four Tau‐derived peptides, 2N, binds to a taxol binding pocket of β‐tubulin located inside microtubules by preincubation with tubulin dimer and subsequent polymerization of the peptide‐tubulin complex. By conjugation of 2N to gold nanoparticles, encapsulation of gold nanoparticles inside microtubules was achieved. The methodology for molecular encapsulation inside microtubules by the Tau‐derived peptide is expected to advance the development of microtubule‐based nanomaterials and nanodevices.